Literature DB >> 7092922

Prolonged hypolactatemia and increased total pyruvate dehydrogenase activity by dichloroacetate.

O B Evans, P W Stacpoole.   

Abstract

Dichloroacetate (DCA) given gastrically as a single dose to healthy, fed rats caused transient lowering of blood glucose, lactate, and pyruvate. Chronic daily dosing caused lowering of these metabolites and a delay in the return of lactate to basal levels for 48 hr after the final dose. DCA caused activation of the pyruvate dehydrogenase complex (PDHC), with acute multiple dosing or chronic daily dosing. The elevated active PDHC persisted for 12 hr following the final dose. In addition, total PDHC activity was increased with chronic dosing and persisted for 48 hr following the final dose. This increase was not blocked by protein synthesis inhibitors. DCA increased isolated hepatocyte [14C-1]pyruvate oxidation and activated hepatocyte PDHC. Glyoxylate and oxalate, hepatic metabolites of DCA, were inhibitory at similar concentrations.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7092922     DOI: 10.1016/0006-2952(82)90019-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  10 in total

1.  Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate.

Authors:  Y Kuroda; M Ito; K Toshima; E Takeda; E Naito; T J Hwang; T Hashimoto; M Miyao; M Masuda; K Yamashita
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation.

Authors:  Nam Ho Jeoung; Pengfei Wu; Mandar A Joshi; Jerzy Jaskiewicz; Cheryl B Bock; Anna A Depaoli-Roach; Robert A Harris
Journal:  Biochem J       Date:  2006-08-01       Impact factor: 3.857

3.  A combined therapeutic approach for pyruvate dehydrogenase deficiency using self-complementary adeno-associated virus serotype-specific vectors and dichloroacetate.

Authors:  Zongchao Han; Kristen Berendzen; Li Zhong; Ira Surolia; Nitin Chouthai; Weihong Zhao; Njeri Maina; Arun Srivastava; Peter W Stacpoole
Journal:  Mol Genet Metab       Date:  2008-02-21       Impact factor: 4.797

4.  Dichloroacetate inhibits glycolysis and augments insulin-stimulated glycogen synthesis in rat muscle.

Authors:  A S Clark; W E Mitch; M N Goodman; J M Fagan; M A Goheer; R T Curnow
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

Review 5.  Pharmacogenetic considerations with dichloroacetate dosing.

Authors:  Margaret O James; Peter W Stacpoole
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

Review 6.  Role of dichloroacetate in the treatment of genetic mitochondrial diseases.

Authors:  Peter W Stacpoole; Tracie L Kurtz; Zongchao Han; Taimour Langaee
Journal:  Adv Drug Deliv Rev       Date:  2008-07-04       Impact factor: 15.470

7.  Ethanol inhalation on 1-[14C]-pyruvate kinetics in mice using a six-compartment closed model.

Authors:  G Wu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.569

Review 8.  Targeting Cancer Metabolism - Revisiting the Warburg Effects.

Authors:  Quangdon Tran; Hyunji Lee; Jisoo Park; Seon-Hwan Kim; Jongsun Park
Journal:  Toxicol Res       Date:  2016-07-30

Review 9.  D-Lactic Acid as a Metabolite: Toxicology, Diagnosis, and Detection.

Authors:  Miroslav Pohanka
Journal:  Biomed Res Int       Date:  2020-06-17       Impact factor: 3.411

10.  Trichloroacetic acid effects on rat liver peroxisomes and enzyme-altered foci.

Authors:  M J Parnell; L D Koller; J H Exon; J M Arnzen
Journal:  Environ Health Perspect       Date:  1986-11       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.